Oramed Pharmaceuticals (ORMP) Interest Coverage Ratio Growth (3y) (2014 - 2026)
Oramed Pharmaceuticals (ORMP) Interest Coverage Ratio Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 28.11% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 29.47% |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | 64.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64.57% |
| Dec 31, 2025 | 31.21% |
| Sep 30, 2025 | -28.13% |
| Jun 30, 2025 | -19.01% |
| Mar 31, 2025 | -235.47% |
| Aug 31, 2021 | -2,213.50% |
| Nov 30, 2019 | -19.86% |
| Aug 31, 2019 | 62.26% |
| May 31, 2019 | -134.57% |
| Feb 28, 2019 | -154.58% |
| Nov 30, 2018 | -247.02% |
| Aug 31, 2018 | 90.76% |
| May 31, 2018 | -31.93% |
| Feb 28, 2018 | 56.12% |
| Nov 30, 2017 | -14.59% |
| Aug 31, 2017 | 45.29% |
| May 31, 2017 | -28.40% |
| Feb 28, 2017 | 24.27% |
| Nov 30, 2016 | 48.93% |
| Aug 31, 2016 | -108.14% |